Gecera Biosciences is an AI-driven platform accelerating next-generation cell and gene therapies. Our agentic AI streamlines design, de-risks CMC, and enables scalable non-viral gene-delivery solutions for gene-replacement and gene-editing programs. With an edge-device-ready prototype for real-time predictive modelling, we provide end-to-end design, IP, and manufacturability insights that help biopharma teams develop safer, faster, and more reliable therapies.